BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 26175867)

  • 1. Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.
    Yoo S; Kim JK; Jeong IG
    Korean J Urol; 2015 Jul; 56(7):487-97. PubMed ID: 26175867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy.
    Muller BG; Kaushal A; Sankineni S; Lita E; Hoang AN; George AK; Rais-Bahrami S; Kruecker J; Yan P; Xu S; de la Rosette JJ; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Urol Oncol; 2015 Oct; 33(10):425.e1-425.e6. PubMed ID: 26259666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
    Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
    Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric magnetic resonance imaging in the detection of prostate cancer.
    Durmus T; Baur A; Hamm B
    Aktuelle Urol; 2014 Mar; 45(2):119-26. PubMed ID: 24700068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy.
    Orczyk C; Rosenkrantz AB; Deng FM; Melamed J; Babb J; Wysock J; Kheterpal E; Huang WC; Stifelman M; Lepor H; Taneja SS
    Urol Oncol; 2016 Jan; 34(1):3.e1-8. PubMed ID: 26338414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of bimodal (18)F-choline-PET/MRI and trimodal (18)F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy.
    Paparo F; Piccardo A; Bacigalupo L; Romagnoli A; Piccazzo R; Monticone M; Cevasco L; Campodonico F; Conzi GM; Carmignani G; Rollandi GA
    Abdom Imaging; 2015 Aug; 40(6):1772-87. PubMed ID: 25579170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
    Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
    AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy.
    Tran M; Thompson J; Böhm M; Pulbrook M; Moses D; Shnier R; Brenner P; Delprado W; Haynes AM; Savdie R; Stricker PD
    BJU Int; 2016 Jan; 117(1):48-54. PubMed ID: 25682968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives.
    Scheenen TW; Rosenkrantz AB; Haider MA; Fütterer JJ
    Invest Radiol; 2015 Sep; 50(9):594-600. PubMed ID: 25974203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.
    Gupta RT; Faridi KF; Singh AA; Passoni NM; Garcia-Reyes K; Madden JF; Polascik TJ
    Urol Oncol; 2014 Nov; 32(8):1292-9. PubMed ID: 24863013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MR Imaging for Detection and Locoregional Staging of Prostate Cancer.
    Bittencourt LK; de Hollanda ES; de Oliveira RV
    Top Magn Reson Imaging; 2016 Jun; 25(3):109-17. PubMed ID: 27187165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies.
    Lee DJ; Ahmed HU; Moore CM; Emberton M; Ehdaie B
    Curr Urol Rep; 2014 Mar; 15(3):390. PubMed ID: 24430171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy.
    Borkowetz A; Renner T; Platzek I; Toma M; Herout R; Baunacke M; Groeben C; Huber J; Laniado M; Baretton GB; Froehner M; Zastrow S; Wirth MP
    Urol Int; 2018; 100(2):155-163. PubMed ID: 29339663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer.
    An JY; Sidana A; Choyke PL; Wood BJ; Pinto PA; Türkbey İB
    Balkan Med J; 2017 Sep; 34(5):388-396. PubMed ID: 28990929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance.
    Porpiglia F; Cantiello F; De Luca S; Manfredi M; Veltri A; Russo F; Sottile A; Damiano R
    BJU Int; 2016 Oct; 118(4):527-34. PubMed ID: 26350955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging treated prostate cancer.
    De Visschere PJ; Vargas HA; Ost P; De Meerleer GO; Villeirs GM
    Abdom Imaging; 2013 Dec; 38(6):1431-46. PubMed ID: 23604966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.
    Gibson E; Bauman GS; Romagnoli C; Cool DW; Bastian-Jordan M; Kassam Z; Gaed M; Moussa M; Gómez JA; Pautler SE; Chin JL; Crukley C; Haider MA; Fenster A; Ward AD
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):188-96. PubMed ID: 27375167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric magnetic resonance imaging versus Partin tables and the Memorial Sloan-Kettering cancer center nomogram in risk stratification of patients with prostate cancer referred to external beam radiation therapy.
    Girometti R; Pancot M; Signor MA; Urbani M; Balestreri L; Zuiani C
    Radiol Med; 2018 Oct; 123(10):778-787. PubMed ID: 29752647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy.
    Reisæter LA; Fütterer JJ; Halvorsen OJ; Nygård Y; Biermann M; Andersen E; Gravdal K; Haukaas S; Monssen JA; Huisman HJ; Akslen LA; Beisland C; Rørvik J
    Acta Radiol; 2015 Apr; 56(4):500-11. PubMed ID: 24819231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.